Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.19, Iss.7, 2009-07, pp. : 1023-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Regulation of FoxP3-Expressing Regulatory T Cells

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 4, 2011-12 ,pp. : 334-346

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets of FoxP3+ Regulatory T Cells

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1136-1143

Bentham Science Publishers

Access to resources Recommend Favorite

The TGF-&bgr; 1/Foxp3 Regulatory Axis in Immune Self-Tolerance: Implications for Health and Disease

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-01 ,pp. : 167-177

Bentham Science Publishers

Access to resources Recommend Favorite

FOXP3 and breast cancer: implications for therapy and diagnosis

By Liu Yang Zheng Pan

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1485-1487

Future Medicine

Access to resources Recommend Favorite

FOXP1: a potential therapeutic target in cancer

By Koon Henry B Ippolito Gregory C Banham Alison H Tucker Philip W

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 955-965

Informa Healthcare

Access to resources Recommend Favorite